FDA Inspection 1225010 — Dong IL Pharm Co., Ltd.
The FDA completed an inspection of Dong IL Pharm Co., Ltd. on Nov 3, 2023 in Eumseong. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 3, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Eumseong (Korea (the Republic of))